Neuphoria Therapeutics Inc. - NEUP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$5.679M
QoQ value delta ($000)
+$3.733M (+191.83%)
Implied price effect (QoQ)
-67.05%
Shares
Total shares
1,465,999
QoQ shares delta
+1,300,486 (+785.73%)
Total shares held by funds (by quarter)

Market chart (NEUP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Lynx1 Capital Management LP 3,395 875,228 0.69%
Shay Capital LLC 655 169,059 0.07%
AdvisorShares Investments LLC 520 134,194 0.09%
DIADEMA PARTNERS LP 194 50,000 0.03%
Ikarian Capital, LLC 184 47,443 0.01%
ADAR1 Capital Management, LLC 116 30,000 0.01%
FNY Investment Advisers, LLC 102 26,500 0.03%
VANGUARD GROUP INC 81 20,950 0.0%
GEODE CAPITAL MANAGEMENT, LLC 67 17,303 0.0%
JANE STREET GROUP, LLC 64 16,597 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 57 14,750 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 54 14,000 0.0%
Persistent Asset Partners Ltd 52 13,403 0.02%
XTX Topco Ltd 46 12,008 0.0%
COMMONWEALTH EQUITY SERVICES, LLC 43 11,207 0.0%
Merck & Co., Inc. 38 10,027 0.01%
UBS Group AG 6 1,652 0.0%
Tower Research Capital LLC (TRC) 5 1,400 0.0%
BANK OF AMERICA CORP /DE/ 0 18 0.0%
MORGAN STANLEY 0 58 0.0%
RHUMBLINE ADVISERS 0 202 0.0%